Bio

As the CEO of Greybrook Securities Inc. and along with his partners, Sasha is responsible for leading the firm’s capital markets and real estate investment strategies. Under his leadership and on behalf of its L.P.’s in over 30 countries, Greybrook’s portfolio has grown to include more than 100 multi-family and residential development projects and over $30 billion worth of estimated completion value. Sasha co-chairs Greybrook’s Investment and Project Advisory Committees which are responsible for approving new acquisitions and actively managing all existing project partnerships. As the former President of Greybrook Health, Sasha also played a key role in several portfolio acquisitions including MacuHealth, Bruder Healthcare and TearLab, as well as the launch of Greenbrook TMS (NASDAQ: GBNH; TSX: GTMS), a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of a major depressive disorder. In 2020, he led the launch of Delos Canada, as well as Greybrook’s investment in Delos Living, LLC a global leader in the health and building sciences.